Why the study?
Do different schedules of OPV and EIPV vaccines confer long-term immunity to poliovirus in children?
Do different schedules of OPV and EIPV vaccines confer long-term immunity to poliovirus in children?
Immunization with combinations of OPV and EIPV confers long-term immunity, with optimal systemic immunity associated with two or more doses of EIPV.
Answers are grounded in this paper and cite their sources.
Supports EIPV-inclusive schedules for durable polio immunity in children; leaves open optimal regimens pending randomized confirmation.
Eighty-six children who completed immunization with the two trivalent poliovirus vaccines, live attenuated (OPV) and enhanced potency inactivated (EIPV), in one of four schedules (OPV-OPV-OPV, EIPV-EIPV-EIPV, EIPV-OPV-OPV, and EIPV-EIPV-OPV) at 1 year of age were monitored serologically over the subsequent 4 years and challenged with OPV at 5 years of age. Each of the immunization groups exhibited an initial 10- to 100-fold decline in neutralizing antibody to poliovirus types 1, 2, and 3 during the first 2 years of follow-up; thereafter antibody titers stabilized. The EIPV-EIPV-OPV group maintained the highest antibody levels throughout the observation period, including the response to OPV challenge at 5 years of age. These data suggest that immunization with OPV, EIPV, and combinations of the two vaccines confers long-term immunity. Optimal systemic immunity was associated with two or more doses of EIPV.
No takes yet. Share an insight, caveat, or question.
Faden et al. (1993) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: